Mylan Triamcinolonacetonidecrème FNA

Mylan Triamcinolonacetonidecrème FNA is a corticosteroid medication used for treating inflammatory skin conditions. The brand Mylan was originally established in the United States and became one of the largest generic pharmaceutical manufacturers in the world.

In 2020, Mylan merged with Upjohn (a former division of Pfizer) to form a new global healthcare company called Viatris. Consequently, Viatris is the current ultimate owner of the Mylan brand name and its associated product lineup. Manufacturing of their products occurs across a vast global network of facilities, including locations in Europe, North America, and India.